Chongqing Peg-bio Biopharm Co., Ltd.
Clinical trials sponsored by Chongqing Peg-bio Biopharm Co., Ltd., explained in plain language.
-
New injection aims to protect cancer patients from Chemotherapy's Blood-Thinning danger
Disease control CompletedThis early-stage study tested a new injection called PN20, given right before chemotherapy, to see if it could safely prevent a dangerous drop in platelets (the cells that help blood clot). It involved 24 adults with lymphoma or solid tumors who had experienced low platelets duri…
Phase: PHASE1 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
First test in humans: can new shot stop drug side effect?
Disease control CompletedThis was the first study in people to check if a new drug called FT1 is safe. Researchers gave FT1 or a placebo (a dummy treatment) to 60 healthy adults to see how their bodies reacted. The main goal was to understand the drug's safety profile and how it moves through the body be…
Phase: PHASE1 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC